Adenosine analogs as methyltransferase inhibitors for treating cancer
US12043645B2 · kind B2 · utility
0Cited by
5References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 26, 2022 |
| Grant date | Jul 23, 2024 |
| Priority date | — |
| Expiry date | Sep 26, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds having methyltransferase inhibitory activity are disclosed. The compounds have the structuresThe compounds disclosed are useful in the treatment of cancer and similar diseases associated with inappropriate methyltransferase activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.